Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.W

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Claridgeon Jul 07, 2019 11:14am

73 Views

Post# 29893320

RE:RE: Competition ???

Fred ... Great post.

________________

fredgoodwinson - (7/7/2019 5:35:35 AM)

RE: Competition ???

fossil - to summarise my post of July 5 at 0534pm this Trial reported to ASCO in May 2016.

The results did not encourage them to proceed with further Trials in that setting (CAVATAK plus mycromycin C). They are now talking about a Clinical Trial with CAVATAK plus a checkpoint inhibitor.

This combination does not appear to have been tested in humans yet so it is impossible to speculate on results.

A more general discourse on the prospects and limitations of oncolytic viral therapy can be found via this link:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084676/

Bullboard Posts

This gambling tech stock might be the safest bet you’ll make this year